| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $765.0M | — | +11.2% |
| Cost of Revenue | $170.0M | — | +9.7% |
| Gross Profit | $595.0M | — | +11.6% |
| R&D Expense | $163.0M | — | +5.8% |
| SG&A Expense | $98.0M | — | -4.9% |
| Operating Income | $56.0M | — | +43.6% |
| Pre-tax Income | $78.0M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $762.0M | -11.2% | +54.3% |
| Short-term Investments | $1.83B | +7.8% | -18.1% |
| Accounts Receivable | $386.0M | -43.8% | +11.9% |
| Current Assets | $3.31B | -9.3% | -1.8% |
| Total Assets | $9.35B | -3.7% | -0.2% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $277.0M | — | +14.9% |
| Capital Expenditures | $1.0M | — | +0.0% |
| Investing Cash Flow | -$78.0M | — | +35.0% |
| Financing Cash Flow | -$293.0M | — | -551.1% |
| Free Cash Flow | $276.0M | — | +15.0% |
| +14.7% |
| Income Tax | $4.0M | — | -33.3% |
| Net Income | $74.0M | — | +19.4% |
| EPS (Basic) | $0.42 | — | +16.7% |
| EPS (Diluted) | $0.42 | — | +20.0% |
| $2.31B |
| -9.5% |
| +0.7% |
| Total Liabilities | $2.45B | -9.7% | -12.5% |
| Stockholders' Equity | $6.90B | -1.4% | +5.1% |